Literature DB >> 23803465

Reprogramming the chromatin landscape: interplay of the estrogen and glucocorticoid receptors at the genomic level.

Tina B Miranda1, Ty C Voss, Myong-Hee Sung, Songjoon Baek, Sam John, Mary Hawkins, Lars Grøntved, R Louis Schiltz, Gordon L Hager.   

Abstract

Cross-talk between estrogen receptors (ER) and glucocorticoid receptors (GR) has been shown to contribute to the development and progression of breast cancer. Importantly, the ER and GR status in breast cancer cells is a significant factor in determining the outcome of the disease. However, mechanistic details defining the cellular interactions between ER and GR are poorly understood. We investigated genome-wide binding profiles for ER and GR upon coactivation and characterized the status of the chromatin landscape. We describe a novel mechanism dictating the molecular interplay between ER and GR. Upon induction, GR modulates access of ER to specific sites in the genome by reorganization of the chromatin configuration for these elements. Binding to these newly accessible sites occurs either by direct recognition of ER response elements or indirectly through interactions with other factors. The unveiling of this mechanism is important for understanding cellular interactions between ER and GR and may represent a general mechanism for cross-talk between nuclear receptors in human disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23803465      PMCID: PMC3799864          DOI: 10.1158/0008-5472.CAN-13-0742

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  40 in total

1.  Estradiol inhibits glucocorticoid receptor expression and induces glucocorticoid resistance in MCF-7 human breast cancer cells.

Authors:  A V Krishnan; S Swami; D Feldman
Journal:  J Steroid Biochem Mol Biol       Date:  2001-04       Impact factor: 4.292

2.  Glucocorticoids regulate gene expression and repress cellular proliferation in human uterine leiomyoma cells.

Authors:  Shannon Whirledge; Darlene Dixon; John A Cidlowski
Journal:  Horm Cancer       Date:  2012-06       Impact factor: 3.869

Review 3.  Glucocorticoid receptor and breast cancer.

Authors:  Myriam Vilasco; Laudine Communal; Najat Mourra; Aurélie Courtin; Patricia Forgez; Anne Gompel
Journal:  Breast Cancer Res Treat       Date:  2011-08-05       Impact factor: 4.872

4.  Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancer.

Authors:  Deng Pan; Masha Kocherginsky; Suzanne D Conzen
Journal:  Cancer Res       Date:  2011-08-25       Impact factor: 12.701

5.  Quantitative analysis of genome-wide chromatin remodeling.

Authors:  Songjoon Baek; Myong-Hee Sung; Gordon L Hager
Journal:  Methods Mol Biol       Date:  2012

6.  Non-classical antiestrogenic actions of dexamethasone in variant MCF-7 human breast cancer cells in culture.

Authors:  F Zhou; B Bouillard; M O Pharaboz-Joly; J André
Journal:  Mol Cell Endocrinol       Date:  1989-10       Impact factor: 4.102

7.  Interaction of the glucocorticoid receptor with the chromatin landscape.

Authors:  Sam John; Peter J Sabo; Thomas A Johnson; Myong-Hee Sung; Simon C Biddie; Stafford L Lightman; Ty C Voss; Sean R Davis; Paul S Meltzer; John A Stamatoyannopoulos; Gordon L Hager
Journal:  Mol Cell       Date:  2008-03-14       Impact factor: 17.970

8.  17 Beta-oestradiol attenuates dexamethasone-induced lethal and sublethal neuronal damage in the striatum and hippocampus.

Authors:  L E Haynes; C L Lendon; D J Barber; I J Mitchell
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

9.  Progesterone, glucocorticoid, but not estrogen receptor mRNA is altered in breast cancer stroma.

Authors:  Robert A Smith; Rod A Lea; Stephen R Weinstein; Lyn R Griffiths
Journal:  Cancer Lett       Date:  2007-05-23       Impact factor: 8.679

10.  Coactivators enable glucocorticoid receptor recruitment to fine-tune estrogen receptor transcriptional responses.

Authors:  Michael J Bolt; Fabio Stossi; Justin Y Newberg; Arturo Orjalo; Hans E Johansson; Michael A Mancini
Journal:  Nucleic Acids Res       Date:  2013-02-26       Impact factor: 16.971

View more
  57 in total

Review 1.  Stress and glucocorticoid receptor transcriptional programming in time and space: Implications for the brain-gut axis.

Authors:  J W Wiley; G A Higgins; B D Athey
Journal:  Neurogastroenterol Motil       Date:  2016-01       Impact factor: 3.598

Review 2.  Minireview: Conversing with chromatin: the language of nuclear receptors.

Authors:  Simon C Biddie; Sam John
Journal:  Mol Endocrinol       Date:  2013-01-01

3.  Meta-analysis of Chromatin Programming by Steroid Receptors.

Authors:  Ville Paakinaho; Erin E Swinstead; Diego M Presman; Lars Grøntved; Gordon L Hager
Journal:  Cell Rep       Date:  2019-09-24       Impact factor: 9.423

4.  Oxytocin receptor DNA methylation in postpartum depression.

Authors:  Mary Kimmel; Makena Clive; Fiona Gispen; Jerry Guintivano; Tori Brown; Olivia Cox; Matthias W Beckmann; Johannes Kornhuber; Peter A Fasching; Lauren M Osborne; Elisabeth Binder; Jennifer L Payne; Zachary Kaminsky
Journal:  Psychoneuroendocrinology       Date:  2016-04-08       Impact factor: 4.905

5.  Anti-Inflammatory Chromatinscape Suggests Alternative Mechanisms of Glucocorticoid Receptor Action.

Authors:  Kyu-Seon Oh; Heta Patel; Rachel A Gottschalk; Wai Shing Lee; Songjoon Baek; Iain D C Fraser; Gordon L Hager; Myong-Hee Sung
Journal:  Immunity       Date:  2017-08-08       Impact factor: 31.745

6.  Ontogeny of hypothalamic glucocorticoid receptor-mediated inhibition of the hypothalamic-pituitary-adrenal axis in mice.

Authors:  Gloria Laryea; Melinda Arnett; Louis J Muglia
Journal:  Stress       Date:  2015-06-11       Impact factor: 3.493

Review 7.  Nuclear receptors in cancer - uncovering new and evolving roles through genomic analysis.

Authors:  Vineet K Dhiman; Michael J Bolt; Kevin P White
Journal:  Nat Rev Genet       Date:  2017-12-27       Impact factor: 53.242

8.  Steroid Receptors Reprogram FoxA1 Occupancy through Dynamic Chromatin Transitions.

Authors:  Erin E Swinstead; Tina B Miranda; Ville Paakinaho; Songjoon Baek; Ido Goldstein; Mary Hawkins; Tatiana S Karpova; David Ball; Davide Mazza; Luke D Lavis; Jonathan B Grimm; Tatsuya Morisaki; Lars Grøntved; Diego M Presman; Gordon L Hager
Journal:  Cell       Date:  2016-04-07       Impact factor: 41.582

Review 9.  Gene regulatory mechanisms underlying sex differences in brain development and psychiatric disease.

Authors:  Devanand S Manoli; Jessica Tollkuhn
Journal:  Ann N Y Acad Sci       Date:  2018-01-24       Impact factor: 5.691

Review 10.  Nuclear receptor crosstalk - defining the mechanisms for therapeutic innovation.

Authors:  Karolien De Bosscher; Sofie J Desmet; Dorien Clarisse; Eva Estébanez-Perpiña; Luc Brunsveld
Journal:  Nat Rev Endocrinol       Date:  2020-04-17       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.